Pricing Log in Create free account

Jazz Pharmaceuticals PLC (JAZZ) vs Bio-Techne Corp (TECH)

Jazz Pharmaceuticals PLC and Bio-Techne Corp are both Biotechnology companies. Jazz Pharmaceuticals PLC is the larger, with a market value of $13.9B against $11.4B — 1.2× the size. Jazz Pharmaceuticals PLC trades at the lower P/E: 13.8× against 62.0×. Jazz Pharmaceuticals PLC grew revenue faster over the last twelve months: 12.6% against −0.38%. Jazz Pharmaceuticals PLC has the higher net margin (20.5% vs 15.0%) and the higher return on invested capital (8.06% vs 7.70%). Across the 22 metrics below, Jazz Pharmaceuticals PLC leads on 16 and Bio-Techne Corp on 6.

Valuation

Metric JAZZ TECH Biotechnology median
P/E 13.77 62.00 8.50
P/S 2.89 9.31 9.71
P/B 2.76 5.37 2.13
Price to free cash flow 9.37 42.98 20.82
EV/EBITDA 9.55 32.24 0.64
EV/Sales 3.35 9.27 9.21
Earnings yield 7.26% 1.61% (33.15%)
Free cash flow yield 10.67% 2.33% (25.50%)

Profitability

Metric JAZZ TECH Biotechnology median
Gross margin 88.42% 65.77% 65.16%
Operating margin 19.49% 20.73% 0.00%
Net margin 20.45% 14.97% 0.00%
Free cash flow margin 30.79% 21.66% 0.00%
Return on equity 22.11% 9.03% (56.36%)
Return on assets 8.54% 7.07% (48.04%)
Return on invested capital 8.06% 7.70% 0.00%

Growth

Metric JAZZ TECH Biotechnology median
Revenue growth (TTM) 12.59% (0.38%) 6.02%
EPS growth (last fiscal year) (167.51%) 152.17% 30.26%
Revenue growth, 5-year CAGR 12.54% 5.47% 9.41%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric JAZZ TECH Biotechnology median
Debt to equity 0.91 0.09 0.00
Current ratio 1.78 4.55 4.72
Net debt to EBITDA 10.96 (0.19) 0.96

Dividend

Metric JAZZ TECH Biotechnology median
Dividend yield — 0.44% 0.09%
Payout ratio — 0.28 —

Size

Metric JAZZ TECH Biotechnology median
Market cap 13.92b 11.37b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack